20n Bio

About:

20n Bio is a VC-backed start-up dedicated to designing and screening cyclic peptides for therapeutics.

Description:

20n Bio (pr. "twenty-n bio") is a VC-backed start-up dedicated to designing and screening cyclic peptides for therapeutics. Launched in 2021 and located in Malvern PA, 20n Bio's mission is addressing unmet medical needs by leveraging high-throughput screening and computing to develop peptide drugs with desired biophysical, functional, and pharmacological properties.

Total Funding Amount:

$3.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Malvern, Pennsylvania, United States

Founded Date:

2021-10-01

Founders:

Mingfu Zhu

Number of Employees:

1-10

Last Funding Date:

2021-12-17

IPO Status:

Private

Industries: